ArticleEuropean heart journal. Cardiovascular pharmacotherapy2018

Market licensing of type 2 diabetes medicinal products based on patient-relevant hard outcomes: is there hope?

Thomas A SchmidtPubMed ↗Publisher ↗

No numbers read from the abstract.